Veratric acid ameliorates metabolic-dysfunction-associated fatty liver disease via targeting PPARG.
Investigation of the protective effects and underlying mechanisms of VA in a high-fat diet induced mouse model of MAFLD demonstrated that VA significantly alleviated HFD-induced weight gain, adipose tissue accumulation, and hepatic steatosis, and suggested its potential as a natural therapeutic agent for MAFLD.